Design, synthesis and biological evaluation of novel pyrazolopyrimidone derivatives as potent PDE1 inhibitors.

Bei Zhang, Yue Huang, Si-Rui Zhang, Meng-Xing Huang, Chen Zhang, Hai-Bin Luo

Bioorganic chemistry 2021 Sep

filter terms:

Phosphodiesterase-1 (PDE1) is a promising drug target closely related to central and peripheral diseases. With the assistance of molecular docking and dynamics simulations, we designed and synthesized a novel series of pyrazolopyrimidone derivatives as effective and metabolically stable inhibitors against PDE1. Most compounds have good inhibitory activities against PDE1 at the concentration of 20 nM. Compound 2j with the IC50 of 21 nM against PDE1B, shows good metabolic stability in the rat liver microsomes (RLM) (t1/2 of 28.5 min), indicating that compound 2j can be used as a tool to explore the molecular recognition mechanism between inhibitors and the target protein PDE1. Copyright © 2021 Elsevier Inc. All rights reserved.

Citation

Bei Zhang, Yue Huang, Si-Rui Zhang, Meng-Xing Huang, Chen Zhang, Hai-Bin Luo. Design, synthesis and biological evaluation of novel pyrazolopyrimidone derivatives as potent PDE1 inhibitors. Bioorganic chemistry. 2021 Sep;114:105104